FDA Authorizes Approval For COVID-19 Pfizer Vaccine
By:
LATF Staff Member
Random Commentary
December 10, 2020,
10:49 pm
Photo Credits: Pexels
Today, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), made up of independent scientific and public health experts from around the country met to discuss the first request for emergency use authorization (EUA) for a vaccine for COVID-19 prevention, submitted by Pfizer Inc. in partnership with BioNTech Manufacturing GmbH.
The FDA authorized the approval of the Pfizer vaccine to for COVID-19.
The FDA is considered the "gold standard" regulator of medical products. The process that the FDA uses to review is respected worldwide because of a well-established history that the FDA has among the most rigorous – and accurate – review processes globally. Normally, the review process for vaccines studied in tens of thousands of people takes months.
Even though the process has been expedited in association with the review of this EUA, the FDA’s expert review staff has reviewed thousands of pages of technical information. These data include, but are not limited to clinical trial data, non-clinical data on the development of the vaccine in the lab, and manufacturing data on how the vaccine is made. FDA career officials have been reviewing the data and information ahead of the public advisory committee meeting to ensure a robust discussion with the independent experts.
FDA Authorizes Approval For COVID-19 Pfizer Vaccine
Today, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), made up of independent scientific and public health experts from around the country met to discuss the first request for emergency use authorization (EUA) for a vaccine for COVID-19 prevention, submitted by Pfizer Inc. in partnership with BioNTech Manufacturing GmbH.
The FDA authorized the approval of the Pfizer vaccine to for COVID-19.
The FDA is considered the "gold standard" regulator of medical products. The process that the FDA uses to review is respected worldwide because of a well-established history that the FDA has among the most rigorous – and accurate – review processes globally. Normally, the review process for vaccines studied in tens of thousands of people takes months.
Even though the process has been expedited in association with the review of this EUA, the FDA’s expert review staff has reviewed thousands of pages of technical information. These data include, but are not limited to clinical trial data, non-clinical data on the development of the vaccine in the lab, and manufacturing data on how the vaccine is made. FDA career officials have been reviewing the data and information ahead of the public advisory committee meeting to ensure a robust discussion with the independent experts.
More From LATF USA
Beloved “Harry Potter” Star Michael Gambon Dies At Age 82
Watch Jodie Foster in “True Detective” Teaser
“NCIS” Star David McCallum Dead at 90: “A Scholar and a Gentleman”
Meet Daytime Beauty Awards Rescue Dogs from Helen Woodward Animal Center
My Magic Carpet Is Stylish and Machine Washable
After 146 Days of Striking Writer’s Reach Tentative Agreement
Watch Sofia Vergara Transform Into “GRISELDA”
Sundance Film Festival Unveils 2024 Official Logo
Watch Nicolas Cage in “Butcher’s Crossing” Trailer
“The Simpsons” Return for 34th Season
LA Lakers Sign Jarred Vanderbilt
This Lake Is The Most Picturesque In The U.S.
RANDOM COMMENTARY
What Is A Hurriquake?
This State Has The Most Credit Card Debt
Obesity Is An Epidemic, Not A Celebration
What Is Meta’s New Threads App?